{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"38.5","value":"0.085"},{"groupId":"OG001","spread":"0.0","value":"0.075"},{"groupId":"OG002","spread":"0.0","value":"0.075"},{"groupId":"OG003","spread":"0.0","value":"0.075"},{"groupId":"OG004","spread":"0.0","value":"0.075"},{"groupId":"OG005","spread":"0.0","value":"0.075"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"title":"Plasma concentration Hx-DR5-01 Cycle 1 Day 1 (predose)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"61.0","value":"0.091"},{"groupId":"OG001","spread":"0.0","value":"0.075"},{"groupId":"OG002","spread":"0.0","value":"0.075"},{"groupId":"OG003","spread":"34.0","value":"0.084"},{"groupId":"OG004","spread":"77.8","value":"0.230"},{"groupId":"OG005","spread":"576.2","value":"0.283"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"2"}],"units":"Participants"}],"title":"Plasma concentration Hx-DR5-01 Cycle 2 Day 1 (predose)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0","value":"0.075"},{"groupId":"OG001","spread":"164.3","value":"0.125"},{"groupId":"OG002","spread":"0.0","value":"0.075"},{"groupId":"OG003","spread":"46.4","value":"0.090"},{"groupId":"OG004","spread":"156.9","value":"0.224"},{"comment":"Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.","groupId":"OG005","spread":"NA","value":"0.739"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"Plasma concentration Hx-DR5-01 Cycle 3 Day 1 (predose)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"77.6","value":"0.094"},{"groupId":"OG001","spread":"0.0","value":"0.075"},{"groupId":"OG002","spread":"0.0","value":"0.075"},{"groupId":"OG003","spread":"0.0","value":"0.075"},{"groupId":"OG004","spread":"0.0","value":"0.075"},{"groupId":"OG005","spread":"0.0","value":"0.075"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"title":"Plasma concentration Hx-DR5-05 Cycle 1 Day 1 (predose)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"83.6","value":"0.097"},{"groupId":"OG001","spread":"0.0","value":"0.075"},{"groupId":"OG002","spread":"0.0","value":"0.075"},{"groupId":"OG003","spread":"0.0","value":"0.075"},{"groupId":"OG004","spread":"161.5","value":"0.155"},{"groupId":"OG005","spread":"372.5","value":"0.240"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"2"}],"units":"Participants"}],"title":"Plasma concentration Hx-DR5-05 Cycle 2 Day 1 (predose)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"94.6","value":"0.101"},{"groupId":"OG001","spread":"138.5","value":"0.119"},{"groupId":"OG002","spread":"0.0","value":"0.075"},{"groupId":"OG003","spread":"58.8","value":"0.094"},{"groupId":"OG004","spread":"0.0","value":"0.075"},{"comment":"Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.","groupId":"OG005","spread":"NA","value":"0.568"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"Plasma concentration Hx-DR5-05 Cycle 3 Day 1 (predose)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"description":"The plasma concentration of Hx-DR5-01 and Hx-DR5-05 are reported.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.","id":"OG000","title":"Biweekly Regimen (GEN1029 0.1 mg/kg)"},{"description":"Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG001","title":"Biweekly Regimen (GEN1029 0.2 mg/kg)"},{"description":"Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG002","title":"Biweekly Regimen (GEN1029 0.3 mg/kg)"},{"description":"Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG003","title":"Biweekly Regimen (GEN1029 1.0 mg/kg)"},{"description":"Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG004","title":"Biweekly Regimen (GEN1029 2.0 mg/kg)"},{"description":"Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG005","title":"Biweekly Regimen (GEN1029 3.0 mg/kg)"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.","reportingStatus":"POSTED","timeFrame":"Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3","title":"Plasma Concentration of Hx-DR5-01 and Hx-DR5-05","type":"SECONDARY","unitOfMeasure":"µg/mL"}